 | • レポートコード：QYR2104Z0831 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、バイオ医薬品のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（モノクローナル抗体、インターフェロン、エリスロポエチン、インスリン、その他）、用途別市場規模（腫瘍、糖尿病、心血管、血友病、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・バイオ医薬品の市場動向 ・企業の競争状況、市場シェア ・バイオ医薬品の種類別市場規模（モノクローナル抗体、インターフェロン、エリスロポエチン、インスリン、その他） ・バイオ医薬品の用途別市場規模（腫瘍、糖尿病、心血管、血友病、その他） ・バイオ医薬品の北米市場規模2016-2027（アメリカ、カナダ） ・バイオ医薬品のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・バイオ医薬品のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・バイオ医薬品の中南米市場規模2016-2027（メキシコ、ブラジル） ・バイオ医薬品の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Roche、Amgen、AbbVie、Sanofi-Aventis、Johnson & Johnson、Pfizer、Novo Nordisk、Eli Lilly、Novartis、Merck） ・結論 |
A biopharmaceutical, also known as a biologic (al) medical product, biological, or biologic, is any pharmaceutical drug product manufactured in, extracted from, or semi synthesized from biological sources. Different from totally synthesized pharmaceuticals, they include vaccines, blood, blood components, allergenic, somatic cells, gene therapies, tissues, recombinant therapeutic protein, and living cells used in cell therapy. Biologics can be composed of sugars, proteins, or nucleic acids or complex combinations of these substances, or may be living cells or tissues. They (or their precursors or components) are isolated from living sources—human, animal, plant, fungal, or microbial.
North America has the highest market share for the estimated period owing to presence of sophisticated healthcare infrastructure, growing geriatric population base and increased healthcare expenditure in the region. Asia Pacific is expected to register the highest growth rate for the forecasted period mainly due to presence of unmet market opportunities in the region.
Market Analysis and Insights: Global Biopharmaceutical Market
The global Biopharmaceutical market size is projected to reach US$ 345420 million by 2026, from US$ 214570 million in 2019, at a CAGR of 7.0% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Biopharmaceutical market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Biopharmaceutical market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Biopharmaceutical market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Biopharmaceutical market.
Global Biopharmaceutical Scope and Market Size
Biopharmaceutical market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Biopharmaceutical market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Monoclonal Antibodies
Interferon
Erythropoietin
Insulin
Other
Segment by Application
Tumor
Diabetes
Cardiovascular
Hemophilia
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Roche
Amgen
AbbVie
Sanofi-Aventis
Johnson & Johnson
Pfizer
Novo Nordisk
Eli Lilly
Novartis
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biopharmaceutical Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Monoclonal Antibodies
1.2.3 Interferon
1.2.4 Erythropoietin
1.2.5 Insulin
1.2.6 Other
1.3 Market by Application
1.3.1 Global Biopharmaceutical Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Tumor
1.3.3 Diabetes
1.3.4 Cardiovascular
1.3.5 Hemophilia
1.3.6 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Biopharmaceutical Market Perspective (2016-2027)
2.2 Biopharmaceutical Growth Trends by Regions
2.2.1 Biopharmaceutical Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Biopharmaceutical Historic Market Share by Regions (2016-2021)
2.2.3 Biopharmaceutical Forecasted Market Size by Regions (2022-2027)
2.3 Biopharmaceutical Industry Dynamic
2.3.1 Biopharmaceutical Market Trends
2.3.2 Biopharmaceutical Market Drivers
2.3.3 Biopharmaceutical Market Challenges
2.3.4 Biopharmaceutical Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Biopharmaceutical Players by Revenue
3.1.1 Global Top Biopharmaceutical Players by Revenue (2016-2021)
3.1.2 Global Biopharmaceutical Revenue Market Share by Players (2016-2021)
3.2 Global Biopharmaceutical Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Biopharmaceutical Revenue
3.4 Global Biopharmaceutical Market Concentration Ratio
3.4.1 Global Biopharmaceutical Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biopharmaceutical Revenue in 2020
3.5 Biopharmaceutical Key Players Head office and Area Served
3.6 Key Players Biopharmaceutical Product Solution and Service
3.7 Date of Enter into Biopharmaceutical Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Biopharmaceutical Breakdown Data by Type
4.1 Global Biopharmaceutical Historic Market Size by Type (2016-2021)
4.2 Global Biopharmaceutical Forecasted Market Size by Type (2022-2027)
5 Biopharmaceutical Breakdown Data by Application
5.1 Global Biopharmaceutical Historic Market Size by Application (2016-2021)
5.2 Global Biopharmaceutical Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Biopharmaceutical Market Size (2016-2027)
6.2 North America Biopharmaceutical Market Size by Type
6.2.1 North America Biopharmaceutical Market Size by Type (2016-2021)
6.2.2 North America Biopharmaceutical Market Size by Type (2022-2027)
6.2.3 North America Biopharmaceutical Market Size by Type (2016-2027)
6.3 North America Biopharmaceutical Market Size by Application
6.3.1 North America Biopharmaceutical Market Size by Application (2016-2021)
6.3.2 North America Biopharmaceutical Market Size by Application (2022-2027)
6.3.3 North America Biopharmaceutical Market Size by Application (2016-2027)
6.4 North America Biopharmaceutical Market Size by Country
6.4.1 North America Biopharmaceutical Market Size by Country (2016-2021)
6.4.2 North America Biopharmaceutical Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Biopharmaceutical Market Size (2016-2027)
7.2 Europe Biopharmaceutical Market Size by Type
7.2.1 Europe Biopharmaceutical Market Size by Type (2016-2021)
7.2.2 Europe Biopharmaceutical Market Size by Type (2022-2027)
7.2.3 Europe Biopharmaceutical Market Size by Type (2016-2027)
7.3 Europe Biopharmaceutical Market Size by Application
7.3.1 Europe Biopharmaceutical Market Size by Application (2016-2021)
7.3.2 Europe Biopharmaceutical Market Size by Application (2022-2027)
7.3.3 Europe Biopharmaceutical Market Size by Application (2016-2027)
7.4 Europe Biopharmaceutical Market Size by Country
7.4.1 Europe Biopharmaceutical Market Size by Country (2016-2021)
7.4.2 Europe Biopharmaceutical Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Biopharmaceutical Market Size (2016-2027)
8.2 Asia-Pacific Biopharmaceutical Market Size by Type
8.2.1 Asia-Pacific Biopharmaceutical Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Biopharmaceutical Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Biopharmaceutical Market Size by Type (2016-2027)
8.3 Asia-Pacific Biopharmaceutical Market Size by Application
8.3.1 Asia-Pacific Biopharmaceutical Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Biopharmaceutical Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Biopharmaceutical Market Size by Application (2016-2027)
8.4 Asia-Pacific Biopharmaceutical Market Size by Region
8.4.1 Asia-Pacific Biopharmaceutical Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Biopharmaceutical Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Biopharmaceutical Market Size (2016-2027)
9.2 Latin America Biopharmaceutical Market Size by Type
9.2.1 Latin America Biopharmaceutical Market Size by Type (2016-2021)
9.2.2 Latin America Biopharmaceutical Market Size by Type (2022-2027)
9.2.3 Latin America Biopharmaceutical Market Size by Type (2016-2027)
9.3 Latin America Biopharmaceutical Market Size by Application
9.3.1 Latin America Biopharmaceutical Market Size by Application (2016-2021)
9.3.2 Latin America Biopharmaceutical Market Size by Application (2022-2027)
9.3.3 Latin America Biopharmaceutical Market Size by Application (2016-2027)
9.4 Latin America Biopharmaceutical Market Size by Country
9.4.1 Latin America Biopharmaceutical Market Size by Country (2016-2021)
9.4.2 Latin America Biopharmaceutical Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Biopharmaceutical Market Size (2016-2027)
10.2 Middle East & Africa Biopharmaceutical Market Size by Type
10.2.1 Middle East & Africa Biopharmaceutical Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Biopharmaceutical Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Biopharmaceutical Market Size by Type (2016-2027)
10.3 Middle East & Africa Biopharmaceutical Market Size by Application
10.3.1 Middle East & Africa Biopharmaceutical Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Biopharmaceutical Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Biopharmaceutical Market Size by Application (2016-2027)
10.4 Middle East & Africa Biopharmaceutical Market Size by Country
10.4.1 Middle East & Africa Biopharmaceutical Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Biopharmaceutical Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Roche Business Overview
11.1.3 Roche Biopharmaceutical Introduction
11.1.4 Roche Revenue in Biopharmaceutical Business (2016-2021)
11.1.5 Roche Recent Development
11.2 Amgen
11.2.1 Amgen Company Details
11.2.2 Amgen Business Overview
11.2.3 Amgen Biopharmaceutical Introduction
11.2.4 Amgen Revenue in Biopharmaceutical Business (2016-2021)
11.2.5 Amgen Recent Development
11.3 AbbVie
11.3.1 AbbVie Company Details
11.3.2 AbbVie Business Overview
11.3.3 AbbVie Biopharmaceutical Introduction
11.3.4 AbbVie Revenue in Biopharmaceutical Business (2016-2021)
11.3.5 AbbVie Recent Development
11.4 Sanofi-Aventis
11.4.1 Sanofi-Aventis Company Details
11.4.2 Sanofi-Aventis Business Overview
11.4.3 Sanofi-Aventis Biopharmaceutical Introduction
11.4.4 Sanofi-Aventis Revenue in Biopharmaceutical Business (2016-2021)
11.4.5 Sanofi-Aventis Recent Development
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Details
11.5.2 Johnson & Johnson Business Overview
11.5.3 Johnson & Johnson Biopharmaceutical Introduction
11.5.4 Johnson & Johnson Revenue in Biopharmaceutical Business (2016-2021)
11.5.5 Johnson & Johnson Recent Development
11.6 Pfizer
11.6.1 Pfizer Company Details
11.6.2 Pfizer Business Overview
11.6.3 Pfizer Biopharmaceutical Introduction
11.6.4 Pfizer Revenue in Biopharmaceutical Business (2016-2021)
11.6.5 Pfizer Recent Development
11.7 Novo Nordisk
11.7.1 Novo Nordisk Company Details
11.7.2 Novo Nordisk Business Overview
11.7.3 Novo Nordisk Biopharmaceutical Introduction
11.7.4 Novo Nordisk Revenue in Biopharmaceutical Business (2016-2021)
11.7.5 Novo Nordisk Recent Development
11.8 Eli Lilly
11.8.1 Eli Lilly Company Details
11.8.2 Eli Lilly Business Overview
11.8.3 Eli Lilly Biopharmaceutical Introduction
11.8.4 Eli Lilly Revenue in Biopharmaceutical Business (2016-2021)
11.8.5 Eli Lilly Recent Development
11.9 Novartis
11.9.1 Novartis Company Details
11.9.2 Novartis Business Overview
11.9.3 Novartis Biopharmaceutical Introduction
11.9.4 Novartis Revenue in Biopharmaceutical Business (2016-2021)
11.9.5 Novartis Recent Development
11.10 Merck
11.10.1 Merck Company Details
11.10.2 Merck Business Overview
11.10.3 Merck Biopharmaceutical Introduction
11.10.4 Merck Revenue in Biopharmaceutical Business (2016-2021)
11.10.5 Merck Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Biopharmaceutical Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Monoclonal Antibodies
Table 3. Key Players of Interferon
Table 4. Key Players of Erythropoietin
Table 5. Key Players of Insulin
Table 6. Key Players of Other
Table 7. Global Biopharmaceutical Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Biopharmaceutical Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Biopharmaceutical Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Biopharmaceutical Market Share by Regions (2016-2021)
Table 11. Global Biopharmaceutical Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Biopharmaceutical Market Share by Regions (2022-2027)
Table 13. Biopharmaceutical Market Trends
Table 14. Biopharmaceutical Market Drivers
Table 15. Biopharmaceutical Market Challenges
Table 16. Biopharmaceutical Market Restraints
Table 17. Global Biopharmaceutical Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Biopharmaceutical Market Share by Players (2016-2021)
Table 19. Global Top Biopharmaceutical Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biopharmaceutical as of 2020)
Table 20. Ranking of Global Top Biopharmaceutical Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Biopharmaceutical Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Biopharmaceutical Product Solution and Service
Table 24. Date of Enter into Biopharmaceutical Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Biopharmaceutical Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Biopharmaceutical Revenue Market Share by Type (2016-2021)
Table 28. Global Biopharmaceutical Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Biopharmaceutical Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Biopharmaceutical Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Biopharmaceutical Revenue Market Share by Application (2016-2021)
Table 32. Global Biopharmaceutical Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Biopharmaceutical Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Biopharmaceutical Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Biopharmaceutical Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Biopharmaceutical Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Biopharmaceutical Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Biopharmaceutical Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Biopharmaceutical Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Biopharmaceutical Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Biopharmaceutical Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Biopharmaceutical Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Biopharmaceutical Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Biopharmaceutical Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Biopharmaceutical Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Biopharmaceutical Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Biopharmaceutical Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Biopharmaceutical Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Biopharmaceutical Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Biopharmaceutical Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Biopharmaceutical Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Biopharmaceutical Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Biopharmaceutical Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Biopharmaceutical Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Biopharmaceutical Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Biopharmaceutical Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Biopharmaceutical Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Biopharmaceutical Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Biopharmaceutical Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Biopharmaceutical Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Biopharmaceutical Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Biopharmaceutical Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Biopharmaceutical Market Size by Country (2022-2027) & (US$ Million)
Table 64. Roche Company Details
Table 65. Roche Business Overview
Table 66. Roche Biopharmaceutical Product
Table 67. Roche Revenue in Biopharmaceutical Business (2016-2021) & (US$ Million)
Table 68. Roche Recent Development
Table 69. Amgen Company Details
Table 70. Amgen Business Overview
Table 71. Amgen Biopharmaceutical Product
Table 72. Amgen Revenue in Biopharmaceutical Business (2016-2021) & (US$ Million)
Table 73. Amgen Recent Development
Table 74. AbbVie Company Details
Table 75. AbbVie Business Overview
Table 76. AbbVie Biopharmaceutical Product
Table 77. AbbVie Revenue in Biopharmaceutical Business (2016-2021) & (US$ Million)
Table 78. AbbVie Recent Development
Table 79. Sanofi-Aventis Company Details
Table 80. Sanofi-Aventis Business Overview
Table 81. Sanofi-Aventis Biopharmaceutical Product
Table 82. Sanofi-Aventis Revenue in Biopharmaceutical Business (2016-2021) & (US$ Million)
Table 83. Sanofi-Aventis Recent Development
Table 84. Johnson & Johnson Company Details
Table 85. Johnson & Johnson Business Overview
Table 86. Johnson & Johnson Biopharmaceutical Product
Table 87. Johnson & Johnson Revenue in Biopharmaceutical Business (2016-2021) & (US$ Million)
Table 88. Johnson & Johnson Recent Development
Table 89. Pfizer Company Details
Table 90. Pfizer Business Overview
Table 91. Pfizer Biopharmaceutical Product
Table 92. Pfizer Revenue in Biopharmaceutical Business (2016-2021) & (US$ Million)
Table 93. Pfizer Recent Development
Table 94. Novo Nordisk Company Details
Table 95. Novo Nordisk Business Overview
Table 96. Novo Nordisk Biopharmaceutical Product
Table 97. Novo Nordisk Revenue in Biopharmaceutical Business (2016-2021) & (US$ Million)
Table 98. Novo Nordisk Recent Development
Table 99. Eli Lilly Company Details
Table 100. Eli Lilly Business Overview
Table 101. Eli Lilly Revenue in Biopharmaceutical Business (2016-2021) & (US$ Million)
Table 102. Eli Lilly Recent Development
Table 103. Novartis Company Details
Table 104. Novartis Business Overview
Table 105. Novartis Biopharmaceutical Product
Table 106. Novartis Revenue in Biopharmaceutical Business (2016-2021) & (US$ Million)
Table 107. Novartis Recent Development
Table 108. Merck Company Details
Table 109. Merck Business Overview
Table 110. Merck Biopharmaceutical Product
Table 111. Merck Revenue in Biopharmaceutical Business (2016-2021) & (US$ Million)
Table 112. Merck Recent Development
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Biopharmaceutical Market Share by Type: 2020 VS 2027
Figure 2. Monoclonal Antibodies Features
Figure 3. Interferon Features
Figure 4. Erythropoietin Features
Figure 5. Insulin Features
Figure 6. Other Features
Figure 7. Global Biopharmaceutical Market Share by Application: 2020 VS 2027
Figure 8. Tumor Case Studies
Figure 9. Diabetes Case Studies
Figure 10. Cardiovascular Case Studies
Figure 11. Hemophilia Case Studies
Figure 12. Other Case Studies
Figure 13. Biopharmaceutical Report Years Considered
Figure 14. Global Biopharmaceutical Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 15. Global Biopharmaceutical Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 16. Global Biopharmaceutical Market Share by Regions: 2020 VS 2027
Figure 17. Global Biopharmaceutical Market Share by Regions (2022-2027)
Figure 18. Global Biopharmaceutical Market Share by Players in 2020
Figure 19. Global Top Biopharmaceutical Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biopharmaceutical as of 2020
Figure 20. The Top 10 and 5 Players Market Share by Biopharmaceutical Revenue in 2020
Figure 21. Global Biopharmaceutical Revenue Market Share by Type (2016-2021)
Figure 22. Global Biopharmaceutical Revenue Market Share by Type (2022-2027)
Figure 23. North America Biopharmaceutical Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. North America Biopharmaceutical Market Share by Type (2016-2027)
Figure 25. North America Biopharmaceutical Market Share by Application (2016-2027)
Figure 26. North America Biopharmaceutical Market Share by Country (2016-2027)
Figure 27. United States Biopharmaceutical Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Canada Biopharmaceutical Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Biopharmaceutical Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Europe Biopharmaceutical Market Share by Type (2016-2027)
Figure 31. Europe Biopharmaceutical Market Share by Application (2016-2027)
Figure 32. Europe Biopharmaceutical Market Share by Country (2016-2027)
Figure 33. Germany Biopharmaceutical Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. France Biopharmaceutical Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. U.K. Biopharmaceutical Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Italy Biopharmaceutical Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Russia Biopharmaceutical Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Nordic Biopharmaceutical Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Biopharmaceutical Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Asia-Pacific Biopharmaceutical Market Share by Type (2016-2027)
Figure 41. Asia-Pacific Biopharmaceutical Market Share by Application (2016-2027)
Figure 42. Asia-Pacific Biopharmaceutical Market Share by Region (2016-2027)
Figure 43. China Biopharmaceutical Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Japan Biopharmaceutical Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. South Korea Biopharmaceutical Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Southeast Asia Biopharmaceutical Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. India Biopharmaceutical Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Australia Biopharmaceutical Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Biopharmaceutical Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Latin America Biopharmaceutical Market Share by Type (2016-2027)
Figure 51. Latin America Biopharmaceutical Market Share by Application (2016-2027)
Figure 52. Latin America Biopharmaceutical Market Share by Country (2016-2027)
Figure 53. Mexico Biopharmaceutical Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Brazil Biopharmaceutical Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Biopharmaceutical Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Middle East & Africa Biopharmaceutical Market Share by Type (2016-2027)
Figure 57. Middle East & Africa Biopharmaceutical Market Share by Application (2016-2027)
Figure 58. Middle East & Africa Biopharmaceutical Market Share by Country (2016-2027)
Figure 59. Turkey Biopharmaceutical Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Saudi Arabia Biopharmaceutical Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. UAE Biopharmaceutical Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. Roche Revenue Growth Rate in Biopharmaceutical Business (2016-2021)
Figure 63. Amgen Revenue Growth Rate in Biopharmaceutical Business (2016-2021)
Figure 64. AbbVie Revenue Growth Rate in Biopharmaceutical Business (2016-2021)
Figure 65. Sanofi-Aventis Revenue Growth Rate in Biopharmaceutical Business (2016-2021)
Figure 66. Johnson & Johnson Revenue Growth Rate in Biopharmaceutical Business (2016-2021)
Figure 67. Pfizer Revenue Growth Rate in Biopharmaceutical Business (2016-2021)
Figure 68. Novo Nordisk Revenue Growth Rate in Biopharmaceutical Business (2016-2021)
Figure 69. Eli Lilly Revenue Growth Rate in Biopharmaceutical Business (2016-2021)
Figure 70. Novartis Revenue Growth Rate in Biopharmaceutical Business (2016-2021)
Figure 71. Merck Revenue Growth Rate in Biopharmaceutical Business (2016-2021)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed
世界のバイオ医薬品受託製造（BCMO）市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Biopharmaceutical Contract Manufacturing Market The global Biopharmaceutical Contract Manufacturing market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analys…- 世界のバイオ医薬品受託製造（BCMO）市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Biopharmaceutical Contract Manufacturing Market The global Biopharmaceutical Contract Manufacturing market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analys…
- 世界のCD38モノクローナル抗体市場規模・現状・予測（2021年-2027年） CD38 monoclonal antibodies target the CD38 surface antigen(sAg) of hematopoietic cells, which is important for cell function. Once CD38 monoclonal antibodies bind to the antigen it inhibits tumour growth by interrupting CD38 functions and causes cell death. CD38 monoclonal antibodies are used to tre…
- 世界の海洋生物製剤市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Marine Biopharmaceutical Market The global Marine Biopharmaceutical market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the …
- 世界のバイオ医薬品CMOサービス市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Biopharmaceutical CMO Services Market The global Biopharmaceutical CMO Services market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data int…